Summary:
This study seeks to learn how well an investigational vaccine works in helping to protect against the different kinds of meningitis germs and how safe this investigational vaccine is when compared with the two types of vaccines currently used to help protect against meningitis.
Qualified Participants Must:
Be 10-25 years old
Not have any chronic immune, neurological, or psychiatric illnesses
Have not previously received prior vaccination with any meningococcal vaccine (except when received at less than 24 months of age)
Qualified Participants May Receive:
- Study related medication at no cost
- Reimbursement for time and travel